Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 1;106(5):e269-e270.
doi: 10.1097/TP.0000000000004090. Epub 2022 Mar 3.

Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients

Jonathan Mitchell  1 , Teresa P-Y Chiang  1 , Jennifer L Alejo  1 , Amy Chang  1 , Aura T Abedon  1 , Robin K Avery  2 , Aaron A R Tobian  3 , Allan B Massie  1   4 , Macey L Levan  1   5 , Daniel S Warren  1 , Jacqueline M Garonzik-Wang  6 , Dorry L Segev  1   4 , William A Werbel  2
Affiliations

Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients

Jonathan Mitchell et al. Transplantation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

D.L.S. received consulting and speaking honoraria from Sanofi, Novartis, CLS Behring, Jazz Pharmaceuticals, Veloxis, Mallinckrodt, and Thermo Fisher Scientific. R.K.A. has study/grant support from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, Regeneron, Takeda/Shire, and Vir/GSK, and he is an associate editor for Transplantation. M.L.L. is the Social Media Editor for Transplantation. The other authors declare no conflicts of interest.

References

    1. Boyarsky BJ, Werbel WA, Avery RK, et al. . Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325:2204–2206. - PMC - PubMed
    1. Qin CX, Moore LW, Anjan S, et al. . Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients. Transplantation. 2021;105:e265–e266. - PMC - PubMed
    1. Werbel WA, Boyarsky BJ, Ou MT, et al. . Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Ann Intern Med. 2021;174:1330–1332. - PMC - PubMed
    1. Hallett AM, Greenberg RS, Boyarsky BJ, et al. . SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients. J Heart Lung Transplant. 2021;40:1579–1588. - PMC - PubMed
    1. Khoury DS, Cromer D, Reynaldi A, et al. . Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27:1205–1211. - PubMed

Publication types